Rx Kids linked to reductions in preterm births and low birthweights, fewer NICU admissions

Direct support during pregnancy and infancy associated with healthier babies and stronger starts

11:52 AM

baby laughing on bed in diaper
Adobe Stock

This article was written by Laura Cane.

A new study found that Rx Kids, the nation’s first community-wide prenatal and infant cash prescription program, was associated with significant improvements in birth outcomes for infants born in Flint, Mich.

The program was associated with reduced low birthweight and preterm birth rates and reduced admissions to the neonatal intensive care unit, according to the study published in The Lancet Public Health.

The findings show that providing direct support during pregnancy and infancy can improve maternal and infant health.

This is among the first population-level studies in the United States showing that direct economic support during pregnancy improves birth outcomes.

Researchers from Michigan State University and the University of Michigan analyzed approximately 4,500 births in Flint between January 2021 and June 2025, comparing outcomes before and after the launch of Rx Kids to similar cities in the state without the program.

Before Rx Kids, low birthweight and preterm birth rates in Flint were increasing from 2021-2023.

After the program began in 2024, those trends reversed. Compared to similar communities, Flint experienced meaningful declines in both outcomes.

Following the launch of Rx Kids, Flint saw an estimated 18% reduction in preterm births and a 27% reduction in low birthweight.

These improvements contributed to a roughly 29% decrease in NICU admissions, generating millions in health care savings.

“When we look at population-level data, we can see that Rx Kids is making a measurable difference in the health of babies at birth,” said Sumit Agarwal, M.D., M.P.H., Ph.D., a physician and health economist at the University of Michigan, Assistant Professor at the U-M Medical School and School of Public Health, and a faculty affiliate of Poverty Solutions at U-M.

"These results show that providing economic support during pregnancy can improve infant health at a population level.”

Previous Rx Kids research has shown a near-universal participation rate with improvements in housing stability, food hardship, maternal mental health, as well as an increase in prenatal care utilization and trust in healthcare institutions.

Along with a decrease in smoking during pregnancy, all of these outcomes are key drivers of healthier births.

“These findings are a big deal and should change how our country thinks about maternal and infant health,” said Mona Hanna, M.D., M.P.H., Director of Rx Kids and Associate Dean of Public Health at Michigan State University College of Human Medicine.

“For decades, we’ve talked about the social drivers of health. This study shows we can actually change them — and improve outcomes at a population level. Poverty is a powerful pathogen harming moms and babies, but these findings prove it is also treatable. When we invest directly in families during pregnancy and infancy, we prevent complications, reduce NICU admissions, and give children a healthier start for life.”

Rx Kids was designed to improve maternal and infant health by addressing the economic shock that accompanies childbirth — when income often drops and expenses surge.

At the same time, this period marks a critical window for child development, with conditions in utero and early infancy shaping lifelong health and development.

The program provides $1,500 during pregnancy and $500 per month during infancy for babies in participating communities.

Since launching in 2024, Rx Kids has expanded to 42 Michigan communities and provided direct support to more than 11,000 families.

The program has demonstrated improvements in family financial stability, prevention of child welfare system involvement, and meaningful economic benefits, with millions of dollars flowing directly into local businesses and communities.

Rx Kids is led by Michigan State University and administered by GiveDirectly, with support from the State of Michigan and a growing family of funders, through a public-private partnership. 

Agarwal is a member of the U-M Institute for Healthcare Policy and Innovation, as is Luke Shaefer, a study co-author and original director of U-M Poverty Solutions who is on leave to the City of Detroit to serve as its inaugural Chief Executive of Health, Human Services and Poverty Solutions.

About Rx Kids

Rx Kids is the nation’s first-ever, community-wide maternal and infant cash prescription program, founded and directed by Mona Hanna, pediatrician and Associate Dean of Public Health at Michigan State University College of Human Medicine. Administered by GiveDirectly, the global leader in cash transfers, Rx Kids has efficiently delivered direct support to thousands of families across dozens of communities—strengthening family financial security, improving maternal and infant health, and boosting local economies.

Rx Kids is built on a strong network of partners who bring together academic leadership, community expertise, and public–private investment to make this vision possible. Co-founded by Michigan State University and Poverty Solutions at the University of Michigan, Rx Kids is implemented in partnership with local Community Champions and stakeholders who drive outreach, engagement, and celebration. Sustained through a robust public–private partnership that blends state investment with philanthropic and other support, Rx Kids reimagines what’s possible with a prescription for health, hope, and opportunity.

Additional authors: In addition to Agarwal, Hanna and Shaefer, the study’s authors are MSU researchers Yasamean Zamani-Hank, Ph.D., Eric Finegood, Ph.D. and Jenny LaChance, M.S.

Paper cited: "The effects of the Rx Kids unconditional cash prescription programme during pregnancy and infancy on birth outcomes in the USA: a population-based, quasi-experimental study," Lancet Public Health. DOI: 10.1016/S2468-2667(26)00055-1

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows


More Articles About:

All Research Topics Wellness and Prevention Children's Health C.S. Mott Children’s Hospital Pregnancy Health Care Delivery, Policy and Economics Postnatal Care Prematurity childbirth Demographics Social Status poverty Medicaid
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Sumit Agarwal

Sumit Agarwal, MD, MPH, PhD

Assistant Professor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Woman's torso in a blue hospital gown, with her hands holding a pregnant belly and an IV in place.
Health Lab

High dose oxytocin protocol linked to lower postpartum hemorrhage rates

A change in how oxytocin is administered after childbirth may help reduce postpartum hemorrhage, a new study suggests.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Elyse celebrates her high school graduation with VanWasshenova
Health Lab

Paralyzed from waist down as a child, patient walks across stage at high school graduation

A tumor on her lower spine paralyzed Elyse Wickenheiser from the waist down as a child. Through successful physical and occupational therapy, she was able to walk across the stage at graduation.
Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.
A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.
Portrait of Peter Mourani, M.D., Professor and Associate Chair of Research for the Department of Pediatrics and Division Director of Pediatric Critical Care Medicine at Michigan Medicine and U-M Health C.S. Mott Children's Hospital.
News Release

U-M-led consortium to receive up to $52 million in NIH funding to study why viral respiratory infections affect children differently

A Michigan Medicine-led research consortium has secured approval for up to $52 million in federal funding to launch a multicenter study examining why some young children recover fully from viral lower respiratory tract infections while others develop severe illness or lasting problems such as asthma.